Bariatric surgery uptake has decreased since the fourth quarter of 2022, coinciding with a rise in prescriptions of semaglutide and tirzepatide for adults with obesity, according to a research letter ...

A Philippine lawmaker on Monday sounded the alarm over the country’s rising obesity problem, following a recent study that found about 41% of the 72 million Filipino adults — translating to 29.5 ...

Twenty point six percent of patients followed a switcher trajectory within 12 months, with higher persistence seen for switchers.

This week, Mad in America examines three studies around mental health diagnosis, psychotropic drug use, obesity, and diabetes ...

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

Metro Creative The prevalence of obesity among adults 60 and older is significant. According to the Centers for Disease ...

FDA now permits Arexvy for adults 18–49 with elevated RSV risk from conditions such as chronic cardiopulmonary or renal disease, obesity, and diabetes. Epidemiology in U.S. adults 18–49 includes ...

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety ...

Junk Food May Erode Bones Long Before Old Age, Study Finds In A Nutshell A 12-year study of more than 163,000 adults found ...

Researchers analyzed nearly 8,000 patients stopping semaglutide or tirzepatide. Most patients maintained weight or continued losing weight after one year, often by restarting therapy, switching ...

The AHA urges doctors to begin screening and treating patients who are still in their 30s, well before the risks of a heart attack and stroke are higher.

On Friday, the U.S. Food and Drug Administration (FDA) expanded the approved age indication for GSK plc’s GSK respiratory syncytial virus vaccine, Arexvy. The approval allows its use in adults aged 18 ...